$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Scientific control of anticancer drugs: full spectrum of side effects and countermeasures during trametinib treatment
2026-02-01 22:25:32
Check Details
Detailed instructions for dabrafenib/dabrafenib: indications, usage and precautions
2026-02-01 22:25:32
Check Details
Cabozantinib Side Effects Analysis: Key Information Patients Need to Know
2026-02-01 22:25:32
Check Details
Osimertinib/Tagrisso Instructions Analysis: Targeted Treatment Options for Patients with Non-Small Cell Lung Cancer
2026-02-01 22:25:32
Check Details
Do I need to limit alcohol consumption while taking Pitobrutinib?
2026-02-01 22:25:32
Check Details
What are the main side effects of Lenvatinib?
2026-02-01 22:25:32
Check Details
How does filazonatant affect hormone levels?
2026-02-01 22:25:32
Check Details
The dispute between domestically produced and imported trametinib: How should patients choose?
2026-02-01 22:25:32
Check Details
Are there any dietary restrictions that require special attention during Besudil treatment?
2026-02-01 22:25:32
Check Details
How many pills per box of dabrafenib/dabrafenib? Key information patients must know before taking medication
2026-02-01 22:25:32
Check Details
Cabozantinib combined with Nivolumab/Ipilimumab maintains PFS benefit in advanced RCC
2026-02-01 22:25:32
Check Details
When is the best time to take Brivaracetam?
2026-02-01 22:25:32
Check Details
1
2
...
1309
1310
1311
1312
1313
1314
1315
...
10225
10226
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Midostaurin vs. Gilteritinib: Key Differences in FLT3-Targeted AML Therapy
2
Lapatinib: A Targeted Anticancer Agent — Not Merely Symptom Relief
3
Filgotinib: Mechanism of Action and Clinical Applications Explained
4
Lapatinib: Proper Administration Guide and Key Precautions
5
Capivasertib (Truqap) Complete Medication Guide: Indications, Dosing, Safety, and Precautions
6
Cemiplimab Storage and Handling Guide
7
ASCO 2026: Spevatamig Opens a New Path in Pancreatic Cancer Immunotherapy
8
FDA Approves First mRNA Flu Vaccine mFLUSIVA
9
Nintedanib Indications Explained: Beyond Idiopathic Pulmonary Fibrosis
10
How Long Does Belumosudil Take to Work for Pulmonary cGVHD?
11
Mavacamten for Obstructive Hypertrophic Cardiomyopathy: Dosing Duration, Efficacy Comparison, and Long-Term Management
12
Belzutifan (Welireg): Comprehensive Guide to the First HIF-2α Inhibitor — Indications, Dosing, and Safety Monitoring